The Food and drug Administration has issued a voluntary recall order affecting the popular stomach acid blocker ranitidine (“Zantac”) after the drug was found to contain the known cancer-causing substance NDMA. In today’s post our dangerous drugs lawyer explains how this recall could lead to hundreds of dangerous/defective drug lawsuits filed by those who developed cancer after taking Zantac.
FDA Orders Leading Heartburn Medication Zantac Immediately Pulled from Market Citing Cancer Danger The U.S. Food and Drug Administration, FDA, took the rare and dramatic step of immediately ordering the widely used heartburn medicine Zantac removed from the market on April 1, 2020. Zantac is the brand name for ranitidine, the primary element of both prescription and over-the-counter versions of this medication. In addition, all generic forms of this drug were ordered off the market by the FDA as well….
Business Interruption Insurance Claims and the Coronavirus Epidemic: Round 2 In a previous post, the business interruption claims lawyer at The Doan Law Firm discussed the issue of business interruption insurance claims related to the Coronavirus epidemic and state/local government-mandatory business closing orders. In the latest twist to arguments as to whether or not insurance carriers are liable for such claims, Insurancejournal.com is reporting that lawmakers in at least 4 states (Massachusetts, New Jersey, New York and Ohio, as of…